Galaxy Surfactants Ltd. · NSE:GALAXYSURF
Galaxy Surfactants — Q2 FY27 Earnings Presentation
18 slides from Galaxy Surfactants's earnings presentation, Nov 4, 2026
Slide 1: Exchange filing cover letter
November 04, 2026 National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, C-1, Block G, Listing Department, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East) Dalal Street, Mumbai – 400 051 Mumbai- 400001 Scrip Symbol: GALAXYSURF Scrip Code: 540935 Sub: Investor presentation
Slide 2: Galaxy Surfactants Limited Result Presentation November'26
Galaxy Surfactants Limited Result Presentation November’26
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se
Slide 4: Company at a Glance
Company at a Glance Extensive R&D Capabilities 7 Strategically Located 215+ Product Grades Facilities with Inhouse 100+ Members Project Execution Capabilities Performance Surfactants: 47+ R&D Centre Specialty Care Products: 168+ Pilot Plant 5 in India Product Application Centre 1 in Egypt 1 in US Pr
Slide 5: Q2 & H1FY27 Performance Highlights
Q2 & H1FY27 Performance Highlights
Slide 6: Management Commentary
Management Commentary “We are pleased with the strong performance delivered in Q2 FY27. The broad-based growth in India, continued recovery in AMET and sustained momentum in Specialty Care demonstrate the strength and resilience of our business. Our ability to make disciplined commercial decisions a
Slide 7: Key Developments
Key Developments Consolidated volumes grew in the high single digits, led by AMET delivered strong mid-teens volume growth across 1 Mid-teens growth in the Performance Surfactants segment and sustained momentum in premium and masstige Specialty Care segment across regions 4 both YoY and QoQ, support
Slide 8: Segment Performance Highlights: Q2 & H1FY27
Segment Performance Highlights: Q2 & H1FY27 Performance Surfactants Revenue Specialty Care Revenue Net Revenue from Operations Q2FY27 ₹ 1,175 cr ₹ 635 cr ₹ 1,810 cr H1FY27 ₹ 2,304 cr ₹ 1,288 cr ₹ 3,592 cr Volume Summary on YoY Q2FY27 H1FY27 Performance Surfactant Mid Teens Growth High Single Digit G
Slide 9: Q2 & H1FY27: Consolidated Performance
Q2 & H1FY27: Consolidated Performance Rs in cr Total Revenue EBITDA PAT +36% +68% +80% 1,817 196 120 1,332 116 66 Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27 +37% +78% +96% 3,602 448 286 2,621 251 146 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 8
Slide 10: Q2 & H1FY27: Revenue Performance
Q2 & H1FY27: Revenue Performance Category Customers Regions 48% 48% 48% 45% 44% 44% 44% 49% 63% 65% 64% 64% 8% 7% 9% 9% 21% 23% 21% 21% 44% 45% 43% 42% 37% 35% 36% 36% 34% 33% 35% 35% Q2FY26 Q2FY27 H1FY26 H1FY27 Q2FY26 Q2FY27 H1FY26 H1FY27 Q2FY26 Q2FY27 H1FY26 H1FY27 Performance Surfactants MNC Cust
Slide 11: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs. In Crores) Q2FY27 Q2FY26 Y-o-Y H1FY27 H1FY26 Y-o-Y FY26 Net Revenue from Operations 1,810.4 1,326.2 36.5% 3,592.3 2,604.1 37.9% 5,248.3 Other Income 6.4 5.8 9.6 17.0 22.1 Total Revenue 1,816.8 1,332.0 36.4% 3,602.0 2,621.1 37.4% 5,270.4 Cost of M
Slide 12: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (Rs. In Crores) Sept'26 Mar'26 Particulars (Rs. In Crores) Sept'26 Mar'26 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 974.2 982.5 EQUITY Right-of-use assets 175.7 182.9 Equity Share Capital 35.5 35.5 Capital work-in-progress 178.9 181.4 Other Eq
Slide 13: Consolidated Cashflow Statement
Consolidated Cashflow Statement Particulars (Rs. In Crores) H1FY27 H1FY26 Cash Flow From Operating Activities : Profit After Tax 285.7 146.0 Operating Profit before working Capital changes 442.4 241.0 Net cash flows generated from/(used) in Operating Activities (A) 76.6 169.4 Net cash flows generate
Slide 14: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement Particulars (Rs. In Crores) Q2FY27 Q2FY26 Y-o-Y H1FY27 H1FY26 Y-o-Y FY26 Net Revenue from Operations 1,233.2 919.0 34.2% 2,498.8 1,793.0 39.4% 3,589.1 Other Income 3.6 13.1 10.4 19.5 29.6 Total Revenue 1,236.9 932.0 32.7% 2,509.2 1,812.6 38.4% 3,618.7 Cost of Mater
Slide 15: Standalone Balance Sheet
Standalone Balance Sheet Particulars (Rs. In Crores) Sept'26 Mar'26 Particulars (Rs. In Crores) Sept'26 Mar'26 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 694.0 690.3 EQUITY Right-of-use assets 141.1 145.4 Equity Share Capital 35.5 35.5 Capital work-in-progress 176.6 176.7 Other Equi
Slide 16: Standalone Cashflow Statement
Standalone Cashflow Statement Particulars (Rs. In Crores) H1FY27 H1FY26 Cash Flow From Operating Activities : Profit After Tax 172.4 88.2 Operating Profit before working Capital changes 289.1 144.9 Net cash flows generated from/(used) in Operating Activities (A) 65.3 18.2 Net cash flows generated fr
Slide 17: Managing Volatility in Raw Material Prices and Currency
Managing Volatility in Raw Material Prices and Currency... Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 3,000 98.00 94.00 2,600 90.00 2,200 86.00 1,800 82.00 78.00 1,400 74.00 1,000 70.00 LA Price USDINR … through Robust Risk Management Practices Source: Market Prices – ICIS – LO
Slide 18: Thank You
Thank You Company Investor Relations Advisors : CIN - U74140MH2010PTC204285 CIN No: L39877MH1986PLC039877 Mr. Mandar Chavan / Mr. Rahul Agarwal Mr. Ruchir Soni mandar.chavan@sgapl.net / Email: Ruchir.Soni@galaxysurfactants.com rahul.agarwal@sgapl.net www.galaxysurfactants.com +91 96993 82195 / +91 9